Poly(ϵ-caprolactone) microcapsules and nanocapsules in drug delivery.

Poly(ϵ-caprolactone) (PCL), a biodegradable and biocompatible polymer, is useful to encapsulate a wide range of drugs making it an interesting material for the preparation of carriers with potential applications in therapeutics. The design and development of those carriers to modulate drug release, to improve the drug stability or apparent solubility in aqueous media, as well as to target tissues and organs are discussed. Microencapsulation is a well-established process in pharmaceutical industry to protect drugs from chemical degradation and to control drug release. In this context, PCL is a useful polymer to prepare microcapsules. Nanoencapsulation, a more recent approach, offers new possibilities in drug delivery. PCL can be used as polymer to prepare different types of nanocapsules presenting diverse flexibility according to the chemical nature of the core. Those nanocapsules are capable of controlling drug release and improving photochemical stability. In addition, they can modulate cutaneous drug penetration/permeation and act as physical sunscreen due to their capability of light scattering. Considering the pharmaceutical point of view, PCL nanocapsules are versatile formulations, once they can be used in the liquid form, as well as incorporated into semi-solid or solid dosage forms.

Citation

Adriana Raffin Pohlmann, Francisco Noe Fonseca, Karina Paese, Cassia Britto Detoni, Karine Coradini, Ruy Cr Beck, Silvia S Guterres. Poly(ϵ-caprolactone) microcapsules and nanocapsules in drug delivery. Expert opinion on drug delivery. 2013 May;10(5):623-38

Mesh Tags

Substances

PMID: 23387432

search → result